Subscribe to RSS
DOI: 10.1055/s-2000-13476
Premature Ovarian Failure and the FMR1 Gene
Publication History
Publication Date:
31 December 2000 (online)
ABSTRACT
FMR1 is an X-linked gene that codes for an RNA binding protein. Expansion of a triplet repeat within exon 1 of the gene causes the fragile X syndrome, which is characterized by mental retardation and various physical anomalies. The triplet repeat in FMR1 can expand to varying degrees. Only the very large expansions in which there is concomitant methylation of the gene cause the fragile X syndrome. Expansions of between 50 and 200 repeats are premutations. Although premutations were originally perceived to be without phenotypic effect, there is now substantial evidence that female carriers of premutations are at increased risk of having early menopause. The FMR1 premutation is also associated with a significant number of cases ascertained because of idiopathic premature ovarian failure, particularly when ovarian failure is a familial trait. The molecular mechanism to explain the association between ovarian failure and premutations is unknown.
KEYWORD
premature ovarian failure - premutation
REFERENCES
- 1 McKinlay S, Jefferys M, Thompson B. An investigation of the age at menopause. J Biosoc Sci . 1972; 4 161-173
- 2 Coulam C B, Adamson S C, Annegers J F. Incidence of premature ovarian failure. Obstet Gynecol . 1986; 67 604-606
- 3 Vegetti W, Tibiletti M G, Testa G. Inheritance in idiopathic premature ovarian failure: analysis of 71 cases. Hum Reprod . 1998; 13 1796-1801
- 4 van Kasteren M Y, Hundscheid R DL, Smits A PT, Cremers F PM, van Zonneveld P, Braat D DM. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease?. Hum Reprod . 1999; 14 2455-2459
- 5 Wyss D, DeLozier C D, Daniell J, Engel E. Structural anomalies of the X chromosome: personal observation and review of non-mosaic cases. Clin Genet . 1982; 21 145-159
- 6 Davi A, Benn P A. X-chromosome abnormalities in women with premature ovarian failure. J Reprod Med . 1999; 44 321-324
- 7 Lippe B. Puberty and its disorders: Turner syndrome. Endocrinol Metab Clin North Am . 1991; 20 121-152
- 8 Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet . 1995; 95 607-629
- 9 Marschio P, Tupler R, Barbierato L. Analysis of Xq deletions. Hum Genet . 1996; 97 375-382
- 10 Powell C M, Taggart R T, Drumheller T C. Molecular and cytogenetic studies of an X: autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet . 1994; 52 19-26
- 11 Therman E, Laxova R, Susman B. The critical region on the human Xq. Hum Genet . 1990; 85 455-461
- 12 Sala C, Arrigo G, Torri G. Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb YAC contig spanning Xq21. Genomics . 1997; 40 123-131
- 13 Aittomaki K, Lucena J LD, Pakarinen P. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell . 1995; 82 959-969
- 14 Bione S, Sala C, Manzini C. A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet . 1998; 62 533-542
- 15 Verkerk A M H J, Pieretti M, Sutcliffe J S. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell . 1991; 65 905-914
- 16 Ashley Jr T C, Warren S T. Trinucleotide repeat expansion and human disease. Annu Rev Genet . 1995; 29 703-728
- 17 Hinds H L, Ashley C T, Sutcliffe J S. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile-X syndrome. Nat Genet . 1993; 3 36-43
- 18 Tamanini F, Meijer N, Verheij C. FMRP is associated to the ribosomes via RNA. Hum Mol Genet . 1996; 5 809-815
- 19 Eichler E E, Richards S, Gibbs R A, Nelson D L. Fine structure of the human FMR1 gene. Hum Mol Genet . 1993; 2 1147-1153
- 20 Sutherland G R, Richards R I. Simple tandem DNA repeats and human genetic disease. Proc Natl Acad Sci U S A . 1995; 92 3636-3641
- 21 Jacobs P A, Bullman H, Macpherson J. Population studies of the fragile(X): a molecular approach. J Med Genet . 1993; 30 454-459
- 22 Brown W T, Nolin S, Houck G. Prenatal diagnosis and carrier screening for fragile X by PCR. Am J Med Genet . 1996; 64 191-196
- 23 Murray A, Youings S, Dennis N. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet . 1996; 5 727-735
- 24 Roussaeu F, Heitz D, Biancalana V. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med . 1991; 325 1673-1681
- 25 Youings S A, Murray A, Dennis N. FRAXA and RAXE: the results of a five year survey. J Med Genet . 2000; 37 415-421
- 26 Sutherland G R, Mulley J C. Fragile X syndrome and fragile XE mental retardation. Prenat Diagn . 1996; 16 1199-11211
- 27 Bell M V, Hirst M C, Nakahori Y. Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell . 1991; 64 861-866
- 28 Sutcliffe J S, Nelson D L, Zhang R. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet . 1992; 1 397-400
- 29 Chudley A E, Hagerman R J. Fragile X syndrome. J Pediatr . 1987; 110 821-831
- 30 Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet . 1996; 64 196-198
- 31 deVries B BA, Mohkamsing S, van den Ouweland M W A. Screening for the fragile X syndrome among the mentally retarded: a clinical study. J Med Genet . 1999; 36 467-471
- 32 Jacobs P A, Sherman S L. The fragile(X): a marker for the Martin-Bell syndrome. Dis Markers . 1985; 3 9-25
- 33 Sherman S L, Morton N E, Jacobs P A, Turner G. The marker(X) syndrome: a cytogenetic and genetic analysis. Ann Hum Genet . 1984; 48 21-37
- 34 Sherman S L, Jacobs P A, Morton N E. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet . 1985; 69 289-299
- 35 Sherman S L, Rogatko A, Turner G. Recurrence risks for relatives in families with an isolated case of the fragile X syndrome. Am J Med Genet . 1988; 31 753-765
- 36 Fisch G S, Snow K, Thibodeau S N. The fragile X premutation in carriers and its effect on mutation size in offspring. Am J Hum Genet . 1995; 56 1147-1155
- 37 Heitz D, Devys D, Imbert G, Kretz C, Mandel J-L. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J Med Genet . 1992; 29 794-801
- 38 Taylor A K, Safanda J F, Fall M Z. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA . 1994; 271 507-514
- 39 Sobesky W E, Taylor A K, Pennington B F. Molecular/clinical correlations in females with fragile X. Am J Med Genet . 1996; 64 340-346
- 40 Cronister A, Schreiner R, Wittenberger M, Amiri K, Harris K, Hagerman R J. Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features. Am J Med Genet . 1991; 38 269-274
- 41 Schwartz C E, Dean J, Howard-Peebles P N. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet . 1994; 51 400-402
- 42 Partington M W, Moore D Y, Turner G M. Confirmation of early menopause in fragile X carriers. Am J Med Genet . 1996; 64 370-373
- 43 Allingham-Hawkins D J, Babul-Hirji R, Chitayat D. Fragile X premutation is a significant risk factor for premature ovarian failure: The International Collaborative POF in Fragile X study: preliminary data. Am J Med Genet . 1999; 83 322-325
- 44 Vianna-Morgants A M, Costa S S, Pavanello R CM, Otto P A, Mingroni-Netto R C. Premature ovarian failure (POF) in Brazilian fragile X carriers. Genet Mol Biol . 1999; 22 471-474
- 45 Uzielli M LG, Guarducci S, Lapi E. Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier identification, from fragile X carrier diagnosis to POF association data. Am J Med Genet . 1999; 84 300-306
- 46 Murray A, Ennis S, MacSwiney F, Webb J, Morton N E. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet . 2000; 8 247-252
- 47 Murray A, Webb J, MacSwiney F, Shipley E L, Morton N E, Conway G S. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod . 1999; 14 1217-1219
- 48 Conway G S, Hettiarachchi S, Murray A, Jacobs P A. Fragile X premutations in familial premature ovarian failure. Lancet . 1995; 346 309-310
- 49 Conway G S, Payne N N, Webb J, Murray A, Jacobs P A. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod . 1998; 13 1184-1188
- 50 Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet . 1998; 35 637-641
- 51 Marozzi A, Vegetti W, Manfredini E. Association between idiopathic premature ovarian failure and fragile X premutation. Hum Reprod . 2000; 15 197-203
- 52 Rousseau F, Rouillard P, Morel M-L, Khandjian E W, Morgan K. Prevalence of carriers of premutation-size alleles of the FMR1 gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet . 1995; 57 1006-1018
- 53 Sherman S L. The high prevalence of fragile X premutation carrier females: is this frequency unique to the French Canadian population?. Am J Hum Genet . 1995; 57 991-994
- 54 Kenneson A, Cramer D W, Warren S T. Fragile X premutations are not a major cause of early menopause. Am J Hum Genet . 1997; 61 1362-1370
- 55 Marozzi A, Dalpra L, Ginelli E. FRAXA premutations are not a cause of familial premature ovarian failure. Hum Reprod . 1999; 14 573-574
- 56 Patsalis P C. FMR1 repeat analysis in patients with ovarian dysfunction or failure. Am J Med Genet . 1999; 83 329-334
- 57 Bulmer M G. The frequency of twins: maternal age and parity. In: The Biology of Twinning in Man London: Oxford University Press 1970: 74-83
- 58 Martin N G, Healey S C, Pangan T S, Heath A C, Turner G. Do mothers of dizygotic twins have earlier menopause: a role for fragile X?. Am J Med Genet . 1997; 69 114-116
- 59 Fryns J-P. The female and the fragile X: a study of 144 obligate female carriers. Am J Med Genet . 1986; 23 157-169
- 60 Turner G, Robinson H, Wake S, Martin N. Dizygous twinning and premature menopause in fragile X syndrome. Lancet . 1994; 344 1500
- 61 Vianna-Morgante A M. Twinning and premature ovarian failure in premutation fragile X carriers. Am J Med Genet . 1999; 83 326
- 62 Healey S C, Duffy D L, Martin N G, Turner G. Is fragile X syndrome a risk factor for dizygotic twinning?. Am J Med Genet . 1997; 72 245-247
- 63 Sherman S L, Meadows K L, Ashley A E. Examination of factors that influence the expansion of the fragile X mutation in a sample of conceptuses from known carrier females. Am J Med Genet . 1996; 64 256-261
- 64 Sherman S L, Turner G, Sheffield L, Laing S, Robinson H. Investigation of the twinning rate in families with the fragile X syndrome. Am J Med Genet . 1988; 30 625-631
- 65 Lyon M F. The X inactivation centre and X chromosome imprinting. Eur J Hum Genet . 1994; 2 255-261
- 66 Belmont J W. Genetic control of X inactivation and processes leading to X-inactivation skewing. Am J Hum Genet . 1996; 58 1101-1109
- 67 Gale R E, Wheadon H, Boulos P, Linch D C. Tissue specificity of X-chromosome inactivation patterns. Blood . 1994; 83 2899-2905
- 68 Hundscheid R DL, Sistermans E A, Thomas C MG. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations. Am J Hum Genet . 2000; 66 413-418
- 69 Hundscheid R DL, Thomas C MG, Braat D DM, Oostra B A, Smits A PT. Reply to the letters from Murray et al and Vianna-Morgante and Costa. Am J Hum Genet . 2000; 67 256-258
- 70 Murray A, Ennis S, Morton N. No evidence for parent of origin influencing premature ovarian failure in fragile X premutation carriers. Am J Hum Genet . 2000; 67 253-254
- 71 Vianna-Morgante A M, Costa S S. Premature ovarian failure is associated with maternally and paternally inherited premutation in Brazilian families with fragile X. Am J Hum Genet . 2000; 67 254-255
- 72 Sherman S L. Premature ovarian failure among fragile X premutation carriers: parent-of-origin effect?. Am J Hum Genet . 2000; 67 11-13
- 73 Syrrou M, Georgiou I, Patsalis P C, Bouba I, Adonakis G, Papoulatos G N. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am J Med Genet . 1999; 84 306-308
- 74 Fisch G, Kenneson A, Warren S, Zelterman D. Evidence of linkage disequilibrium between POF1 and FRAXAC1. Am J Hum Genet . 1998; 63(Suppl) A212
- 75 Feng Y, Zhang F, Lokey L K. Translational suppression by trinucleotide repeat expansion at FMR-1 Science . 1995; 268 731-734
- 76 Tassone F, Hagerman R J, Taylor A K, Gane L W, Godfrey T E, Hagerman P J. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet . 2000; 66 6-16
- 77 Davis B M, Mccurrach M E, Taneja K L, Singer R H, Housman D E. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A . 1997; 94 7388-7393
- 78 Philips A V, Timchenko L T, Cooper T A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science . 1998; 280 737-740
- 79 Singer R H. Triplet-repeat transcripts: a role for RNA in disease. Science . 1998; 280 696-698
- 80 Timchenko L T, Timchenko N A, Caskey C T, Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet . 1996; 5 115-123
- 81 Timchenko L T. Human genetics '99: trinucleotide repeats. Myotonic dystrophy: the role of RNA CUG triplet repeats. Am J Hum Genet . 1999; 64 360-364
- 82 Bachner D, Manca A, Steinbach P. Enhanced expression of the murine Fmr1 gene during germ cell proliferation suggests a special function in both the male and the female gonad. Hum Mol Genet . 1993; 2 2043-2050
- 83 Braat D DM, Smits A PT, Thomas C MG. Menstrual disorders and endocrine profiles in fragile X carriers prior to 40 years of age: a pilot study. Am J Med Genet . 1999; 83 327-331